Search results
Results from the WOW.Com Content Network
Respiratory syncytial virus (RSV), [a] also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. [2] Its name is derived from the large cells known as syncytia that form when infected cells fuse. [2] [3]
A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. [1] RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year. [2] The RSV vaccines Arexvy , [3] Abrysvo , [4] and Mresvia [5] are approved for medical use in the United States.
Fusion glycoprotein F0 of the human respiratory syncytial virus (RSV) is a critical fusion glycoprotein that facilitates entry of the virus into host cells by mediating the fusion of the viral and cellular membranes.
Human respiratory syncytial virus (HRSV) is the most known orthopneumovirus because of its direct correlation and importance in humans. RSV is the leading viral agent among pneumoviruses in pediatric upper respiratory diseases globally. New pneumoviruses have been discovered in the Netherlands among 28 children according to studies.
Bovine respiratory syncytial virus (BRSV) is pneumovirus closely related to human respiratory syncytial virus (RSV) that is a common cause of respiratory disease in cattle, particularly calves. It is a negative-sense , single-stranded RNA virus that replicates in the cytoplasm of the cell. [ 1 ]
Respiratory syncytial virus vaccine This page was last edited on 17 October 2024, at 11:51 (UTC). Text is available under the Creative Commons Attribution ...
Respiratory syncytial virus, causing respiratory disease; Rous sarcoma virus, causing cancer in chickens; Organisations
Respiratory syncytial virus G protein is a glycoprotein produced by respiratory syncytial virus. [1] [2] [3] Some features of the G protein suggest it could be important to respiratory syncytial virus vaccine or antiviral drug target design. [4] [5]